10 Large-Cap Stocks Rising on Unusually Heavy Volume Large-caps are the preferred trading vehicles for many institutions. The reasons: ample liquidity, analyst coverage and widely available information. Despite their hefty size, some still are capable of delivering respectable earnings and sales growth quarter after quarter.

*The IBD SmartSelect Composite Rating combines all five SmartSelect Ratings. Of the five, the Earnings Per Share Rating and Relative Price Strength Rating get the most weight; stocks?percentage of their high price is also considered. Ratings are from 1-99, with 99 being the best.

**The Accumulation/Distribution Rating uses a price and volume formula to determine if a stock is under accumulation (buying) or distribution (selling) in the last 13 weeks. A signals heavy buying; E is heavy selling.

1. Freeport-McMoRan Copper & Gold (FCX) - View IBD Stock Checkup   Composite Rating: 99*. The New Orleans-based firm is the world抯 largest publicly traded copper producer. It has delivered triple-digit sales growth for the past two quarters. Mutual fund ownership has jumped to 568 funds from 427 over the past three quarters. Volume % Change**: +80%.   2. Nokia (NOK) - View IBD Stock Checkup   Composite Rating: 97. The Finnish cell phone maker is hovering near six-year highs. Cowen & Co. recently upgraded the firm to outperform from neutral. The company reports earnings on Oct. 18. Analysts see profit rising 48% to 43 cents a share. Volume % Change: +65%.   3. Oracle (ORCL) - View IBD Stock Checkup   Composite Rating: 97. The database maker fiscal Q1 earnings jumped 26% to 22 cents a share, beating views. Its new license sales rose 35%, passing management and analyst expectations Volume % Change: +53%.   4. POSCO (PKX) - View IBD Stock Checkup   Composite Rating: 95. The South Korean steel producer sales growth has climbed for four straight quarters. Its Accumulation/Distribution Rating ?a measure of institutional activity ?has improved to a highest possible "A." Volume % Change: +41%.   5. Tenaris (TS) - View IBD Stock Checkup   Composite Rating: 94. The Luxembourg-based maker of tubular steel products recently regained its 50-day moving average on strong volume. Tenaris sees full-year sales growing 43% to about $11 billion Volume % Change: +60%.   6. McDonald (MCD) - View IBD Stock Checkup   Composite Rating: 94. The fast-food restaurant operator is trading near record levels. Earlier this month, the company said its global same-store sales rose 8.1% in August. It also boosted its dividend by 50% to $1.50 a share. Volume % Change: +41%.   7. Monsanto (MON) - View IBD Stock Checkup   Composite Rating: 93. The Missouri-based agricultural chemicals maker raised its full-year earnings outlook to $2 a share, passing views of $1.83. Previously, it pegged earnings between $1.75 and $1.80 a share. Volume % Change: +58%.   8. Autodesk (ADSK) - View IBD Stock Checkup   Composite Rating: 92. The software maker is trading near all-time highs, but big upside volume has been lacking in recent weeks. Analysts see profit growing 42% to $1.89 a share. Volume % Change: +74%.   9. Coach (COH) - View IBD Stock Checkup   Composite Rating: 91. The luxury handbag maker sees limited growth opportunities in Europe, but sees Japan as a different story. It expects its market share to grow to 15% over the next few years from its current 9%. Volume % Change: +43%.   10. Syngenta Ag (SYT) - View IBD Stock Checkup   Composite Rating: 87. The Swedish firm makes crop protection products such as herbicides and seed treatments. It抯 the second-ranked stock by way of Overall Rating in IBD抯 Agricultural Operations group. Volume % Change: +57%.